Thirty patients with high-grade malignant lymphoma were treated with ifosfamide-VP16213-methotrexate (IMVP-16) combination chemotherapy after failing to respond completely or after relapsing on CHOP-like therapy. Responders to the salvage therapy subsequently were treated with ablative chemotherapy
Thirty-one-year survival following chemotherapy and autologous bone marrow in malignant lymphoma
β Scribed by Haurani, Farid I.
- Book ID
- 101214369
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 33 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
β¦ Synopsis
A 21-year-old woman with malignant lymphoma received a large dose of nitrogen mustard followed by autologous bone marrow. She achieved a complete remission that lasted 21 years. This was followed in a span of 10 years by two relapses that responded to chemotherapy and splenectomy. Death resulted from sepsis. At autopsy, there was minimal evidence of malignant lymphoma, but evidence for side effects of chemotherapy was present. Am.
π SIMILAR VOLUMES
## Background: Over the past decade, high dose chemotherapy with autologous bone marrow (hdc-abmt) support has been used increasingly in the treatment of patients with breast cancer. in evaluating the results of hdc-abmt in patients with breast cancer, an assessment of quality of life can add to th
Preliminary evidence indicates that physical exercise may be an effective strategy for the rehabilitation of cancer patients following high dose chemotherapy (HDC) and bone marrow transplantation (BMT), but the focus of this research has been on physical fitness and medical outcomes. In the present